Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study

BACKGROUND AND OBJECTIVE: The long term effects of fingolimod, an oral treatment for relapsing-remitting (RR) multiple sclerosis (MS), on blood circulating B and T cell subtypes in MS patients are not completely understood. This study describes for the first time the longitudinal effects of fingolim...

Full description

Saved in:

Bibliographic Details
Main Authors:	Claes, Nele, Dhaeze, Tessa, Fraussen, Judith, Broux, Bieke, Van Wijmeersch, Bart, Stinissen, Piet, Hupperts, Raymond, Hellings, Niels, Somers, Veerle
Format:	Artigo
Language:	Inglês
Published:	Public Library of Science 2014
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4215872/ https://ncbi.nlm.nih.gov/pubmed/25360562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0111115
Tags:	Add Tag No Tags, Be the first to tag this record!

Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study

Similar Items